Anwar M Hashem Selected Research

Anwar M Hashem Research Topics

Disease

15	COVID-19 06/2022 - 05/2020
12	Infections 11/2022 - 12/2009
12	Human Influenza (Influenza) 10/2019 - 12/2009
3	Neoplasms (Cancer) 05/2022 - 06/2011
2	Hepatocellular Carcinoma (Hepatoma) 05/2022 - 06/2011
2	Virus Diseases (Viral Diseases) 05/2020 - 06/2011
1	Thrombocytopenia (Thrombopenia) 04/2022
1	Thrombosis (Thrombus) 04/2022
1	Hemoglobinopathies 01/2022
1	Hyperferritinemia 01/2022
1	Reinfection 11/2021
1	Breast Neoplasms (Breast Cancer) 01/2021
1	Neoplasm Metastasis (Metastasis) 01/2021
1	Sickle Cell Anemia (Hemoglobin S Disease) 01/2021
1	Pain (Aches) 01/2021
1	Carcinogenesis 01/2021
1	Weight Loss (Weight Reduction) 01/2021
1	Coronavirus Infections 01/2020
1	Immune System Diseases (Immune Disorders) 01/2020
1	Vesicular Stomatitis 01/2020
1	Hemorrhage 10/2019
1	Tachypnea 01/2019
1	Pneumonia (Pneumonitis) 01/2019
1	Respiratory Syncytial Virus Infections 01/2019
1	Airway Obstruction (Choking) 01/2019
1	Influenza in Birds (Avian Flu) 01/2013

Drug/Important Bio-Agent (IBA)

13	AntibodiesIBA 04/2022 - 08/2010
11	VaccinesIBA 04/2022 - 12/2009
6	Proteins (Proteins, Gene)FDA Link 01/2022 - 07/2014
5	EnzymesIBA 06/2022 - 12/2009
5	Neuraminidase (Sialidase)IBA 11/2013 - 12/2009
5	EpitopesIBA 11/2013 - 12/2010
4	Neutralizing AntibodiesIBA 06/2022 - 01/2020
4	Amino Acids FDA Link 05/2018 - 06/2013
3	Pharmaceutical PreparationsIBA 01/2022 - 12/2009
3	Immunoglobulin G (IgG)IBA 12/2020 - 10/2020
3	Immunoglobulin M (IgM)IBA 12/2020 - 10/2020
3	Antiviral Agents (Antivirals)IBA 05/2020 - 12/2009
2	Peptides (Polypeptides)IBA 11/2022 - 12/2010
2	ImmunosorbentsIBA 06/2022 - 10/2020
2	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 05/2022 - 01/2021
2	ChAdOx1 nCoV-19IBA 04/2022 - 01/2022
2	Hydroxyurea (Hydrea)FDA LinkGeneric 01/2022 - 01/2021
2	COVID-19 VaccinesIBA 01/2022 - 11/2021
2	Messenger RNA (mRNA)IBA 01/2022 - 01/2021
2	NucleoproteinsIBA 12/2020 - 07/2014
2	CD40 Ligand (CD40L)IBA 10/2019 - 07/2014
2	Viral HemagglutininsIBA 04/2011 - 12/2010
1	Ad26COVS1IBA 04/2022
1	Platelet Factor 4IBA 04/2022
1	BNT162 VaccineIBA 01/2022
1	Nucleocapsid ProteinsIBA 01/2022
1	Angiotensin-Converting Enzyme 2IBA 01/2022
1	mRNA VaccinesIBA 11/2021
1	WastewaterIBA 04/2021
1	Indicators and Reagents (Reagents)IBA 04/2021
1	PlatinumIBA 03/2021
1	Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)IBA 01/2021
1	IronIBA 01/2021
1	GANT 61IBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	AZD4547IBA 01/2021
1	AntigensIBA 12/2020
1	Chloroquine (Aralen)FDA LinkGeneric 05/2020
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 05/2020
1	Therapeutic UsesIBA 05/2020
1	Viral RNAIBA 10/2019
1	Interleukin-1 (Interleukin 1)IBA 01/2019
1	Interleukin-6 (Interleukin 6)IBA 01/2019
1	CytokinesIBA 01/2019
1	Interleukin-17 (Interleukin 17)IBA 01/2019
1	Respiratory Syncytial Virus VaccinesIBA 01/2019
1	Broadly Neutralizing AntibodiesIBA 01/2015
1	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2015
1	LigandsIBA 07/2014
1	Monoclonal AntibodiesIBA 11/2013
1	Virus ReceptorsIBA 01/2013
1	InterferonsIBA 06/2011
1	Transcription Factors (Transcription Factor)IBA 06/2011
1	Cytochrome P-450 CYP3AIBA 06/2011
1	Immune Sera (Antisera)IBA 04/2011
1	Nucleic AcidsIBA 12/2009
1	Amantadine (Aman)FDA LinkGeneric 12/2009
1	Aurintricarboxylic AcidIBA 12/2009

Therapy/Procedure

2	Therapeutics 01/2021 - 12/2009
1	Patient Isolation 06/2022